These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 10604572
21. Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure. Sangwan V, Paliouras GN, Cheng A, Dubé N, Tremblay ML, Park M. J Biol Chem; 2006 Jan 06; 281(1):221-8. PubMed ID: 16234234 [Abstract] [Full Text] [Related]
22. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure. Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM. Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692 [Abstract] [Full Text] [Related]
23. Tumor necrosis factor-alpha induces apoptosis of enterocytes in mice with fulminant hepatic failure. Song HL, Lu S, Liu P. World J Gastroenterol; 2005 Jun 28; 11(24):3701-9. PubMed ID: 15968724 [Abstract] [Full Text] [Related]
24. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M. Kidney Int; 2003 Jan 28; 63(1):72-82. PubMed ID: 12472770 [Abstract] [Full Text] [Related]
25. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Kim SJ, Kim JK, Lee DU, Kwak JH, Lee SM. Eur J Pharmacol; 2010 Jun 10; 635(1-3):188-93. PubMed ID: 20303938 [Abstract] [Full Text] [Related]
33. N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice. Wang H, Xu DX, Lu JW, Zhao L, Zhang C, Wei W. Acta Pharmacol Sin; 2007 Nov 10; 28(11):1803-9. PubMed ID: 17959032 [Abstract] [Full Text] [Related]
34. Combined treatment with verrucarin A and tumor necrosis factor-α sensitizes apoptosis by overexpression of nuclear factor-kappaB-mediated Fas. Jayasooriya RGPT, Moon DO, Park SR, Choi YH, Asami Y, Kim MO, Jang JH, Kim BY, Ahn JS, Kim GY. Environ Toxicol Pharmacol; 2013 Sep 10; 36(2):303-310. PubMed ID: 23708311 [Abstract] [Full Text] [Related]
37. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages. Xie C, Jingjing W, Li X, Zeng F, Ma L, Li C, Wei Z, Peng A, Chen L. Int Immunopharmacol; 2014 Aug 10; 21(2):261-8. PubMed ID: 24861250 [Abstract] [Full Text] [Related]
38. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N. Am J Pathol; 2000 Mar 10; 156(3):997-1007. PubMed ID: 10702415 [Abstract] [Full Text] [Related]
39. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation. Qin Y, Camoretti-Mercado B, Blokh L, Long CG, Ko FD, Hamann KJ. J Immunol; 2002 Oct 01; 169(7):3536-44. PubMed ID: 12244143 [Abstract] [Full Text] [Related]